Dr. Ashish Jha emphasized that the vaccines are safe and will help schools return to normal.
However, just 27% of parents say they're currently planning to vaccinate their young children, according to a. About 33% of parents said they would take a"wait and see" approach to the vaccine, while 30% said they would"definitely not" vaccinate their children. Another small group said they would only vaccinate their young children if they were required to do so.the vaccine is safe and effective, and is key to helping the country recover from the pandemic.
"I think it's great for kids, it offers that protection we've been waiting for," said Dr. Ashish Jha, dean of Brown University's School of Public Health."It also means that every school-aged kid in America is now going to be eligible for a vaccine. That really has a profound effect on schools. ... We're going to have fewer quarantines. Schools are going to get back to the more normal we've been waiting for. This is really important.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Long Covid: What to Know About Lingering Symptoms of a Covid-19 InfectionWhat causes long Covid? Are certain people more susceptible to getting it? What’s the deal with long Covid and brain fog? Here’s what the latest research, as well as doctors and patients, say about the condition.
Les mer »
Kids and the COVID-19 vaccine: 5 questions answered by pediatriciansThe nation's top health experts have said that getting more kids vaccinated will be key to managing the pandemic in the U.S.
Les mer »
CDC Recommends COVID-19 Vaccine for Younger ChildrenThe expert panel decided the benefits of getting vaccinated outweighed the risks for children ages 5 to 11 years
Les mer »
Analysis: Country by country, scientists eye beginning of an end to the COVID-19 pandemicAs the devastating Delta variant surge eases in many regions of the world, scientists are charting when, and where, COVID-19 will transition to an endemic disease in 2022 and beyond, according to Reuters interviews with over a dozen leading disease experts.
Les mer »
Pfizer expects 2021, 2022 COVID-19 vaccine sales to total at least $65 blnPfizer Inc on Tuesday said it expected this year to sell $36 billion of the COVID-19 vaccine it developed with German partner BioNTech and forecast another $29 billion in sales in 2022, topping analyst estimates for both years.
Les mer »
CDC panel weighs risks and benefits of COVID-19 vaccine for young childrenCDC’s advisors are weighing who will get the most benefit as they deliberate whether to recommend the shots for up to 28 million more children, or perhaps only for those most vulnerable to serious illness.
Les mer »